SCHEMBL16455682

SCHEMBL16455682

Cc1cc(C)c(S(=O)(=O)N2CCCCC2)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ ALDH1A1 P00352 5/20 0.50
▸ TSHR P16473 5/20 0.47
▸ GAA P10253 1/20 0.47
▸ NPBWR1 P48145 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ TP53 P04637 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ CNR2 P34972 1/20 0.46
▸ ATM Q13315 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16455755 0.84 ALDH1A1 (0.58) L3MBTL1SMN1; SMN2KDM4ELMNAKMT2A
SCHEMBL17808302 0.83 SMN1; SMN2 (0.56) POLBL3MBTL1SMN1; SMN2KDM4ELMNA
SCHEMBL23833576 0.79 KDM4E (0.55) POLBL3MBTL1SMN1; SMN2KDM4ELMNA
SCHEMBL2705569 0.71 SMN1; SMN2 (0.85) POLBL3MBTL1SMN1; SMN2LMNAMEN1
SCHEMBL27263637 0.71 UHRF1 (0.45) L3MBTL1SMN1; SMN2KDM4ELMNAMEN1
SCHEMBL14501626 0.71 L3MBTL1 (0.65) POLBL3MBTL1SMN1; SMN2KDM4ELMNA
SCHEMBL10126519 0.71 SMN1; SMN2 (0.64) POLBL3MBTL1SMN1; SMN2KDM4ELMNA
SCHEMBL21986228 0.70 POLB (0.64) POLBL3MBTL1SMN1; SMN2KDM4EMEN1
SCHEMBL4555634 0.70 ALDH1A1 (0.71) POLBL3MBTL1SMN1; SMN2LMNAMEN1
SCHEMBL15872007 0.70 ALDH1A1 (0.71) POLBL3MBTL1SMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9611248-B2 Chemical compounds SYNGENTA LIMITED (GB) 2017-04-04 — — US disclosed
US-20160159767-A1 CHEMICAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed
WO-2015018432-A1 PYRROLONE DERIVATIVES AS HERBICIDES SYNGENTA PARTICIPATIONS AG (CH) 2015-02-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160159767-A1 CHEMICAL COMPOUNDS DDT, CBR3, CYP1B1 POLB 1307/4885L3MBTL1 1725/4885SMN1; SMN2 4478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback